Adiga Life Sciences, Inc. Report issue

For profit Phase 2
Founded: Hamilton ON Canada (2013)
Status: Left NME R&D (2020)

Organization Overview

First Clinical Trial
2013
NCT00867906
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Conjunctivitis (Phase 2)

Hypersensitivity (Phase 2)

Rhinitis (Phase 2)

Rhinitis, Allergic (Phase 2)

Rhinitis, Allergic, Seasonal (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 16
  • # of Trial APIs: 5